Rani Therapeutics Holdings (RANI) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to -$5.4 million.
- Rani Therapeutics Holdings' Other Gross PP&E Adjustments rose 1550.76% to -$5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 million, marking a year-over-year increase of 1550.76%. This contributed to the annual value of -$2.3 million for FY2024, which is 20353.51% down from last year.
- Rani Therapeutics Holdings' Other Gross PP&E Adjustments amounted to -$5.4 million in Q3 2025, which was up 1550.76% from -$5.3 million recorded in Q2 2025.
- In the past 5 years, Rani Therapeutics Holdings' Other Gross PP&E Adjustments ranged from a high of $2.6 million in Q4 2022 and a low of -$6.4 million during Q3 2024
- Over the past 5 years, Rani Therapeutics Holdings' median Other Gross PP&E Adjustments value was -$1.8 million (recorded in 2022), while the average stood at -$2.7 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first surged by 69721.58% in 2022, then tumbled by 27044.28% in 2024.
- Rani Therapeutics Holdings' Other Gross PP&E Adjustments (Quarter) stood at -$431000.0 in 2021, then soared by 697.22% to $2.6 million in 2022, then fell by 12.08% to $2.3 million in 2023, then crashed by 203.54% to -$2.3 million in 2024, then plummeted by 132.31% to -$5.4 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$5.4 million for Q3 2025, versus -$5.3 million for Q2 2025 and -$5.2 million for Q1 2025.